DCs form a dense network at barrier surfaces such as skin, lung, and the intestinal lamina propria (LP). LP DCs acquire antigens from both commensal microbes and invading pathogens. They are thought to direct and regulate local innate immune responses, as well as determine the balance between tolerogenic and inflammatory adaptive responses ([@bib38]; [@bib14]).

LP APCs can be phenotypically divided into two major developmentally distinct populations. The first, CD103^−^CD11b^+^ CX~3~CR1^hi^ cells, derive from Ly6C^hi^ monocyte precursors and share a common transcriptome with tissue-resident macrophages ([@bib5]; [@bib67]; [@bib52]). These cells produce IL-10, which is thought to be required for FoxP3^+^ regulatory T cell (T reg cell) maintenance in the LP ([@bib16]; [@bib29]). However, they do not express CCR7 in the steady state and their ability to migrate to mesenteric lymph nodes (MLNs) remains controversial ([@bib59]; [@bib18]). The second population, CD103^+^ DCs, develops from a dedicated Flt3L-dependent conventional DC precursor and has a transcriptome similar to other DC lineages ([@bib5]; [@bib67]; [@bib52]). These cells express CCR7 and migrate to MLNs under steady-state and inflammatory conditions ([@bib59]). They have been shown to transport *Salmonella enterica* into the mesenteric LN (MLN) and produce retinoic acid (RA), inducing differentiation of CCR9^+^ gut-homing T reg cells both in vitro and in vivo ([@bib15]; [@bib63]; [@bib39]; [@bib5]; [@bib60]).

Importantly, CD103^+^ DCs can be subdivided into two ontogenetically distinct subsets based on the expression of CD11b ([@bib5]). CD103^+^CD11b^−^ DCs depend on the transcription factors BatF3, IRF8, and Id2 ([@bib27]; [@bib20]). Despite the absence of CD103^+^CD11b^−^ DCs in BatF3^−/−^ mice, alterations in bulk T cell homeostasis or intestinal inflammation are not observed ([@bib20]). Development of the second CD103^+^ DC subset, CD103^+^CD11b^+^ DC, requires Notch2 signaling ([@bib48]). These DCs are able to induce differentiation of Th17 cells in vitro, and the frequency of Th17 cells is reduced in the LP of CD11c-Cre Notch2^fl/fl^ mice ([@bib17]; [@bib24]; [@bib48]). In addition to this adaptive function, CD103^+^CD11b^+^ DCs are thought to exert innate immune functions through their ability to detect flagellin via Toll-like receptor 5 (TLR5; [@bib65]; [@bib24]). Flagellin administration induces IL-22 from innate lymphoid cells in the LP and is thought to enhance innate resistance to intestinal pathogens ([@bib66]; [@bib44]). Elaboration of IL-22 depends on TLR5 and DC-derived IL-23. Reduced IL-22 production in Flt3^−/−^ mice and the expression of TLR5 by CD103^+^CD11b^+^ DCs has suggested that this DC subset is required for IL-22 production ([@bib45]). Additionally, IL-23--dependent IL-22 is required for innate resistance to *Citrobacter rodentium*, a mouse model for enteropathogenic *Escherichia coli* infection ([@bib69]).

Mouse models that allow for in vivo deletion of DC subsets are valuable tools to study DC function ([@bib11]). However, multiple DC subsets are often affected, preventing the attribution of particular functions to an individual subset. Flt3^−/−^ mice have greatly reduced numbers of CD103^+^CD11b^+^ DCs in the LP, but ∼40% of CD103^+^CD11b^−^ DCs, as well as a statistically significant number of CD103^−^CD11b^+^ cells, are also absent ([@bib5]). Likewise, CD11c-Cre Notch2^fl/fl^ mice lack CD103^+^CD11b^+^ DC, but have a concomitant increase in CD103^+^CD11b^−^ LP DC, along with a loss of splenic CD11b^+^ Esam^hi^ DCs ([@bib48]).

To investigate the function of DC subsets in the skin, we previously generated mice that ablate epidermal Langerhans cells (LCs) based on transgenic expression of human Langerin (huLangerin-DTA mice; [@bib40]). In this study, we report that, in addition to LCs, CD103^+^CD11b^+^ LP DCs selectively express human Langerin (huLangerin) and are absent in these mice. Because all other DCs in the LP and MLN are intact, we use huLangerin-DTA mice, as well as Batf3^−/−^ mice that lack CD103^+^CD11b^−^ DC, to dissect the in vivo roles of specific CD103^+^ DC subsets in establishing innate and adaptive immune responses.

RESULTS
=======

CD103^+^CD11b^+^ LP DCs express human Langerin
----------------------------------------------

LP DCs in C57BL/6 mice do not express Langerin under steady-state conditions ([@bib9]). In contrast, Langerin expressing DCs have been reported in human LP ([@bib42]; [@bib10]). To confirm Langerin expression in human LP, we examined fresh samples of human intestine by immunofluorescence. We observed numerous cells expressing Langerin that coexpressed MHC-II, identifying them as LP APCs ([Fig. 1, A and B](#fig1){ref-type="fig"}).

![**LP DCs express human Langerin.** (A) Human ileal biopsies were stained with DAPI (blue) and isotype control (left) or anti-huLangerin antibody (right, red). (B) Human colonic villus stained with DAPI (blue) and antibodies against HLA-DR (red) and Langerin (green). (C) Ileum from wild-type littermates (control) or huLangerin-Cre x *Rosa26*-Stop^fl^-YFP (HuLang-Cre YFP) mice stained with anti-YFP (green), anti-MHCII (red), and DAPI (blue). (D) Flow cytometric analysis of LP cells isolated from mice of the indicated genotypes. (E) Small intestinal LP suspensions from HuLang-Cre YFP mice were gated on live single cells before gating for total YFP^+^ cells (left). YFP^+^ cells (black dots) were then compared for expression of MHCII and CD11c with total live gated cells (gray contour, right). (F) Cell suspensions from the indicated tissues of murine Langerin-EGFP mice were analyzed for MHCII and GFP expression. (G) Live single cells from HuLang-Cre YFP mice gated on CD11c^hi^ and MHCII^+^ cells and subgated for CD103 and CD11b. (H) YFP expression in the indicated subsets from HuLang-Cre YFP (black line) or littermate control (shaded gray) mice. (I) huLangerin expression in the indicated DC subsets isolated from transgene^+^ (black line) or littermate control (shaded gray) mice. All data are representative of at least 2 independent experiments.](JEM_20130728_Fig1){#fig1}

In mice, endogenous Langerin is expressed primarily by LCs and CD103^+^ dermal DCs in the skin. In contrast, human LCs express Langerin, but DCs in the dermis do not ([@bib31]). We previously reported that the human promoter of the gene *langerin* drives expression in murine LCs, but not CD103^+^ dermal DCs ([@bib7]). Because human Langerin transgenic mice appear to recapitulate the human pattern of Langerin expression in the skin, we considered the possibility that human Langerin might be expressed by LP DCs in these transgenic mice.

We previously generated huLangerin-Cre x *Rosa26*-Stop^fl^-YFP mice (henceforth referred to as huLang-Cre YFP) that faithfully report the expression of transgenic human Langerin ([@bib41]). Immunofluorescent microscopy of the small intestine of huLang-Cre YFP mice revealed numerous cells coexpressing MHC-II and huLangerin in the LP that were not present in control littermates ([Fig. 1 C](#fig1){ref-type="fig"}). huLangerin-expressing cells could also be detected in the colon, but at a reduced frequency (unpublished data). YFP^+^ MHC-II^+^ cells could be easily detected by flow cytometry of collagenase-digested small intestinal LP ([Fig. 1 D](#fig1){ref-type="fig"}). Importantly, all YFP^+^ cells were CD11c^hi^ and MHC-II^+^, identifying them as LP APCs ([Fig. 1 E](#fig1){ref-type="fig"}). In contrast, reporter mice for murine Langerin (muLangerin-eGFP; [@bib46]) confirmed that murine langerin was not expressed in MHCII^+^ cells of the LP, although it was easily detected in epidermal LCs ([Fig. 1 F](#fig1){ref-type="fig"}). Thus, the human BAC containing the gene for *langerin* that we have previously used to generate several lines of transgenic mice recapitulates the human pattern of Langerin expression and drives expression in intestinal LP DCs.

To determine which DC subsets express huLangerin, single-cell suspensions were generated from the small intestinal LP of huLang-Cre YFP and control mice. To identify LP DCs, we gated on CD11c^hi^ MHC-II^+^ cells, further dividing them into three subsets (I--III) based on their expression of CD103 and CD11b ([Fig. 1 G](#fig1){ref-type="fig"}) ([@bib5]). We did not observe YFP expression in CD103^+^CD11b^−^ DCs, CD103^−^CD11b^+^ macrophages, or control littermates ([Fig. 1 H](#fig1){ref-type="fig"}). In contrast, we observed robust YFP expression in CD103^+^CD11b^+^ DCs isolated from huLang-Cre YFP mice. Because YFP expression in these Cre reporter mice could potentially result from huLangerin transgene expression in a DC precursor population, we stained DCs from transgenic mice ([@bib4]) with a huLangerin-specific antibody. As expected, we observed huLangerin protein expression in CD103^+^CD11b^+^ DC, but not in other DC/macrophage subsets or transgene-negative controls ([Fig. 1 I](#fig1){ref-type="fig"}). Thus, the gene for human *langerin* drives YFP and Langerin expression selectively in CD103^+^CD11b^+^ LP DCs of BAC transgenic mice. Because we observed few huLangerin^+^ DCs in the colon, which agrees with previous data showing that CD103^+^CD11b^+^ DCs are predominantly present in the small bowel ([@bib17]), we focused on the small intestinal LP for the remainder of our studies.

huLangerin-DTA mice lack CD103^+^CD11b^+^ LP DCs
------------------------------------------------

huLangerin-DTA BAC transgenic mice were engineered to express an attenuated form of *diphtheria* toxin driven by the same human Langerin promoter used by huLangerin-Cre mice. In the skin, these mice have a selective ablation of epidermal LCs ([@bib40]). To determine whether LP DCs are also ablated in these mice, we compared DC populations in the small intestinal LP of huLangerin-DTA and littermate control mice. Using the same gating strategy shown in [Fig. 1 G](#fig1){ref-type="fig"}, we noted a near-complete absence of CD11c^hi^ MHC-II^+^ CD103^+^CD11b^+^ DCs ([Fig. 2, A and B](#fig2){ref-type="fig"}, subset II). Importantly, the numbers of CD103^+^CD11b^−^ DCs (subset I) and CD103^−^CD11b^+^ macrophages (subset III) in the LP were unaffected. We noted a similar absence of CD103^+^CD11b^+^ DCs in the draining MLNs of huLangerin-DTA mice ([Fig. 2 C](#fig2){ref-type="fig"}).

![**CD103^+^CD11b^+^ LP DCs are ablated in huLangerin-DTA mice.** (A) Flow cytometry of CD11c^hi^ MHCII^+^ gated LP cells isolated from littermate control or huLangerin-DTA mice analyzed for CD103 and CD11b expression. (B) The number of cells for each subset in A is shown (*n* = 6--8 mice per genotype). (C) MLN cells analyzed as in A. (D--E) Flow cytometry of live single cells from LP (D) or MLN (E) isolated from littermates of the indicated genotypes. All data are representative of at least three experiments. Statistics were calculated using an unpaired Student's *t* test (\*, P ≤ 0.05).](JEM_20130728_Fig2){#fig2}

CD103 expression by DCs can be regulated by environmental stimuli ([@bib19]). Therefore, to confirm ablation of CD103^+^CD11b^+^ DCs in huLangerin-DTA mice, we bred huLangerin-DTA mice with YFP reporter mice. As expected, a population of CD11c^+^ cells expressing YFP could be detected in the LP of huLang-Cre YFP but not control mice. These cells were absent from the LP of huLang-Cre YFP x huLangerin-DTA mice ([Fig. 2 D](#fig2){ref-type="fig"}). The same was observed in the MLNs ([Fig. 2 E](#fig2){ref-type="fig"}). These findings in independently derived transgenic lines confirm that huLangerin drives transgene expression in CD103^+^CD11b^+^ DCs in the LP and MLN. This DC subset is selectively ablated in huLangerin-DTA transgenic mice, providing a novel and powerful tool to study the function of CD103^+^CD11b^+^ DCs in vivo.

Functional characterization of huLangerin-DTA mice
--------------------------------------------------

huLangerin-DTA mice have been well characterized ([@bib40]; [@bib35]). They are long-lived and do not develop spontaneous autoimmunity. Because the ablation of CD103^+^CD11b^+^ LP DCs in these mice was previously unappreciated, we tested their response to an intestinal inflammatory challenge. Dextran-sodium sulfate (DSS) generates an acute hemorrhagic enterocolitis and is a standard assay of the intestinal inflammatory response ([@bib68]). We administered DSS in the drinking water of huLangerin-DTA and littermates for 10 d and monitored their weight loss. As expected, treated groups lost a significant amount of weight. However, huLangerin-DTA mice lost weight at the same rate as littermate controls when treated with either 2% (unpublished data) or 5% DSS ([Fig. 3 A](#fig3){ref-type="fig"}). Treated control and huLangerin-DTA animals also exhibited an identical degree of colonic shortening, a measure of colitis severity ([Fig. 3 B](#fig3){ref-type="fig"}). Thus, CD103^+^CD11b^+^ LP DCs are not required for the development of, or protection from, DSS enterocolitis.

![**CD103^+^CD11b^+^ DCs are not required for IL-22 production or resistance to *Citrobacter* or *Salmonella.*** (A) Groups of 4--6 littermate control (triangles) and huLangerin-DTA (diamonds) mice were given water (open symbols) or 5% DSS (filled symbols) *ad libitum* for the indicated number of days and monitored for weight loss. Data are presented as the mean ± SEM. (B) Colon length upon sacrifice at day 10. Representative data from 1 of 2 independent experiments is shown. (C) Animals were treated intravenously with PBS (open symbols) or 1 µg flagellin (closed symbols) and euthanized 2 h later for LP mRNA extraction and qPCR analysis. CD11c-DTR mice were treated with 1 µg diphtheria toxin 18 h before flagellin injection. Data are normalized to HPRT and displayed as fold change over PBS-treated mice. (D) Control (triangles) or huLangerin-DTA (diamonds) littermates and IL-23 p19^−/−^ mice (squares) were infected with 2 × 10^9^ *C. rodentium* and monitored for weight loss. Data are presented as the mean ± SEM with at least 3 mice per group pooled from 2 independent experiments. One animal succumbed due to unrelated causes and was excluded from the analysis. (E) Mice were pretreated with 20 mg streptomycin sulfate 24 h before infection with 5 × 10^7^ *Salmonella* strain SL1344 by gavage. MLNs were harvested 48 h later and analyzed for CFU. (F and G) Mice were orogastrically infected with 10^8^ AroA^−^ *Salmonella*-2W1S. Indicated organs were harvested 10 d later for CFU. Dashed lines represent the limit of detection. (H) Spleens and MLN were pooled from uninfected (Naive) and *Salmonella*-2W1S infected mice after 10 d and magnetically enriched for 2W1S-specific cells. Flow plots represent the binding of 2W1S-I-Aβ tetramer by CD4 T cells. Numbers represent the total number of tetramer-specific cells. Flow plots in H are representative of three experiments. All symbols represent individual mice pooled from two (C, F, and G) or four (E) independent experiments. Lines in E--G represent the geometric mean. Statistics were calculated using unpaired Student's *t* tests (nd, not detected; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001).](JEM_20130728_Fig3){#fig3}

CD103^+^CD11b^+^ DCs express TLR5 ([@bib65]; [@bib24]) and are reportedly required for IL-23--dependent amplification of IL-22 production by gut innate lymphoid cells in response to intravenously administered flagellin ([@bib45]). Because these studies were performed in mice with defects in multiple gut DC lineages (e.g., CD11c-DTR and Flt3^−/−^ mice), we tested the response to intravenous flagellin in huLangerin-DTA mice. As expected, we observed a dramatic increase in LP IL-22 mRNA expression in the small intestine of control mice 2 h after treatment with flagellin. This increase was absent in IL-23 p19^−/−^ mice and significantly reduced in CD11c-DTR mice treated with diphtheria toxin. IL-22 production was unaffected in huLangerin-DTA mice ([Fig. 3 C](#fig3){ref-type="fig"}), indicating that CD103^+^CD11b^+^ DCs are not required for innate immune responses to i.v. flagellin.

To determine whether CD103^+^CD11b^+^ DCs are required for IL-22--IL-23--dependent immune responses during infection, we orogastrically inoculated mice with 2 × 10^9^ *C. rodentium*. As previously reported ([@bib3]; [@bib51]), IL-23 p19^−/−^ mice lost a significant amount of weight beginning at day 4 after infection ([Fig. 3 D](#fig3){ref-type="fig"}) and succumbed in 8--12 d (unpublished data). However, huLangerin-DTA mice and their wild-type littermates did not lose weight or succumb to *C. rodentium* infection ([Fig. 3 D](#fig3){ref-type="fig"}). We considered that, though they may be an important source of IL-23, CD103^+^CD11b^+^ DCs might not be required for protection from *Citrobacter* because of the lack of TLR5 ligation by this aflagellate pathogen ([@bib43]). We therefore infected mice with *S. enterica* serovar Typhimurium, using an antibiotic pretreatment model of acute *S. enterica*--induced gastroenteritis ([@bib2]). We observed that CFU of *S. enterica* in the MLN was significantly increased in IL-23 p19^−/−^ mice 48 h after infection, but was unaffected in huLangerin-DTA mice ([Fig. 3 E](#fig3){ref-type="fig"}). Thus, CD103^+^CD11b^+^ DCs do not appear to be required for resistance to IL-22--IL-23--dependent infections.

To investigate whether adaptive immunity to *S. enterica* requires CD103^+^CD11b^+^ DCs, we orally infected mice with *S. enterica* that expresses a previously characterized 2W1S CD4 T cell epitope, allowing us to track a pathogen-specific adaptive immune response during infection ([@bib53]; [@bib54]). 10 d after inoculation, near the peak of the response, huLangerin-DTA mice bore a bacterial burden equivalent to that of littermate controls in both the MLN ([Fig. 3 F](#fig3){ref-type="fig"}) and spleen ([Fig. 3 G](#fig3){ref-type="fig"}). This was also true at later time points (unpublished data). As expected, *Samonella*-2W1S infection led to an ∼20-fold increase in the number of 2W1S-specific endogenous CD4 T cells. Notably, the lack of CD103^+^CD11b^+^ LP DCs did not impair the development of a pathogen-specific CD4 T cell response ([Fig. 3 H](#fig3){ref-type="fig"}). Thus, CD103^+^CD11b^+^ LP DCs are not required for adaptive immune responses to a flagellated gut pathogen.

CD103^+^CD11b^+^ DCs are required for Th17 homeostasis
------------------------------------------------------

To determine whether the absence of CD103^+^CD11b^+^ DCs affects steady-state helper T cell development in vivo, we compared the numbers of CD4 T cell subsets in huLangerin-DTA and control mice. We found that CD4 T cell numbers in the MLN were not altered by the absence of CD103^+^CD11b^+^ DCs ([Fig. 4 A](#fig4){ref-type="fig"}). In the small intestinal LP, however, we noted a nonsignificant trend toward fewer CD4 T cells in huLangerin-DTA mice ([Fig. 4 B](#fig4){ref-type="fig"}). The number of Foxp3^+^ T reg cells in the MLN and LP was unaffected ([Fig. 4, C and D](#fig4){ref-type="fig"}).

![**LP Th17 cells require CD103^+^CD11b^+^ DCs through an MHC II independent mechanism.** (A--D) CD4 cells gated as CD3ε^+^ TCRγδ^−^ CD8α^−^ CD4^+^ were isolated and enumerated from indicated tissues by flow cytometry. T reg cells were detected by intracellular staining for FoxP3 directly ex vivo. Data are presented as mean ± SEM and pooled from five independent experiments (*n* = 8--10 mice per group). (E) LP suspensions were restimulated ex vivo for 3 h with PMA/ionomycin and stained for intracellular cytokines. Representative flow plots gated on LP CD4 T cells as in A--D. (F--H) Frequency of restimulated CD4^+^ LP T cells expressing indicated cytokines by flow cytometry. (I) Surface expression of MHCII on small intestinal LP DC subsets gated as CD3ε^−^ B220^−^ CD64^−^ CD11c^+^ cells and subgated for CD103 and CD11b, as in [Fig. 1 G](#fig1){ref-type="fig"}. Flow plots represent two independent experiments. Symbols represent individual mice and are pooled from 5 (E--G) or 3 (H) independent experiments. Statistics were calculated by unpaired Student's *t* tests, with Welch's correction for unequal variance in B and D. \*\*\*, P ≤ 0.001.](JEM_20130728_Fig4){#fig4}

To examine the requirement of CD103^+^CD11b^+^ LP DCs for other T helper subsets, we compared the expression of IL-17A and IFN-γ in PMA/ionomycin-stimulated cells isolated from the LP of huLangerin-DTA and littermate control mice. We observed that the frequency of CD4 T cells expressing IL-17 was greatly reduced in huLangerin-DTA mice, whereas the expression of IFN-γ was unaffected ([Fig. 4, E--G](#fig4){ref-type="fig"}). As previously noted, CD4 T cells expressing IL-17 in the MLN were rare ([@bib1]). The observed differences were not caused by differential carriage of segmented filamentous bacteria because littermates were used as controls. In addition, we confirmed equivalent carriage of segmented filamentous bacteria by quantitative PCR (unpublished data). Finally, we examined the LP of huLangerin-Cre x I-Aβ^fl/fl^ mice. Notably, these mice had a normal frequency of Th17 cells in the LP compared with controls ([Fig. 4 H](#fig4){ref-type="fig"}), despite the fact that \>90% of CD103^+^CD11b^+^ DCs lacked expression of MHC-II ([Fig. 4 I](#fig4){ref-type="fig"}). Thus, Th17 development in the LP depends on the presence of CD103^+^CD11b^+^ DCs but does not require their cognate interaction with CD4 T cells.

CD103^+^ DCs are required for LP T reg cells
--------------------------------------------

Batf3^−/−^ mice lack CD103^+^CD11b^−^ DCs in the LP, as well as other peripheral tissues. Despite this deficiency, no abnormalities in T cell or T reg cell homeostasis, or steady-state intestinal inflammation, were noted ([@bib20]). We generated huLangerin-DTA x BatF3^−/−^ animals (henceforth referred to as DTAxBatF3^−/−^). As expected, in the resulting DTAxBatF3^−/−^ mice, both subsets of CD103^+^ DCs were constitutively deleted in the LP and MLN ([Fig. 5, A and B](#fig5){ref-type="fig"}). DTAxBatF3^−/−^ animals were long lived, did not develop autoimmunity (unpublished data), and did not show altered susceptibility to DSS ([Fig. 5, C and D](#fig5){ref-type="fig"}). We observed that the additional absence of CD103^+^CD11b^+^ DCs did not alter the number CD4 T cells in the MLN ([Fig. 5 E](#fig5){ref-type="fig"}). However, as we observed with huLangerin-DTA mice, there was a nonsignificant trend toward fewer total CD4 T cells in the LP of DTAxBatF3^−/−^ animals ([Fig. 5 F](#fig5){ref-type="fig"}).

![**CD103^+^CD11b^+^ DCs are non-redundant for Th17 development, whereas CD103^+^CD11b^−^ DCs are dispensable.** (A and B) Flow cytometry of CD11c^hi^ MHCII^+^ cells from LP (A) or MLN (B) of the indicated genotypes. Data represent 3 experiments (*n* = 3--5 per group). (C) Groups of 3--5 BatF3^−/−^ (circles) and DTAxBatF3^−/−^ (triangles) littermate mice were given water (open symbols) or 5% DSS (filled symbols) *ad libitum* for the indicated number of days and monitored for weight loss. Data are presented as the mean ± SEM (D) Colon length upon sacrifice at day 10. Symbols represent individual mice and lines represent the mean. C and D represent one of two experiments. (E and F) Cells were isolated from indicated tissues and CD4 T cell numbers enumerated as previously described. (*n* = 10--12 mice per group). (G and H) Frequency of restimulated CD4 LP T cells producing the indicated cytokines. Data are presented as mean ± SEM and symbols represent individual mice. Animals in E--H are pooled from three independent experiments. Statistics were calculated by unpaired Student's *t* tests, using Welch's correction in C. \*, P ≤ 0.05; \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001).](JEM_20130728_Fig5){#fig5}

We next examined the presence of Th17 and Th1 cells in the small intestinal LP. We compared DTAxBatF3^−/−^ mice with littermate BatF3^−/−^ controls to ensure that any observed changes were not caused by alterations in the gut microbiota. We observed reduced Th17 cells in DTAxBatF3^−/−^ mice compared with Batf3^−/−^ mice. However, Th1 cells in the LP were not affected ([Fig. 5, G and H](#fig5){ref-type="fig"}). These data are quite similar to those obtained with huLangerin-DTA mice not bred to Batf3^−/−^ animals ([Fig. 4 F](#fig4){ref-type="fig"}). Because the additional deletion of CD103^+^CD11b^−^ DCs did not alter the presence of Th17 or Th1 cells in the LP, these data demonstrate that CD103^+^CD11b^+^ DCs are specifically required for steady-state Th17 development.

As T reg cell numbers are unaffected in huLangerin-DTA mice ([Fig. 4, C and D](#fig4){ref-type="fig"}) and BatF3^−/−^ mice ([@bib20]), we next examined T reg cell development in DTAxBatF3^−/−^ mice. The number of FoxP3^+^ T reg cells in the MLN was unaffected in DTAxBatF3^−/−^ mice lacking both CD103^+^ DC subsets ([Fig. 6 A](#fig6){ref-type="fig"}). However, there was a significant reduction in the number of FoxP3^+^ T reg cells in the LP of DTAxBatF3^−/−^ mice compared with BatF3^−/−^ littermates ([Fig. 6 B](#fig6){ref-type="fig"}). We next investigated expression of gut-homing chemokine receptors on FoxP3^+^ T reg cells in the MLN. The frequency of T reg cells expressing the RA-inducible gut-homing receptor CCR9 was greatly diminished in DTAxBatF3^−/−^ mice compared with both wild-type mice and mice lacking only one CD103^+^ DC subset ([Fig. 6, C and D](#fig6){ref-type="fig"}). We therefore conclude that CD103^+^CD11b^+^ and CD103^+^CD11b^−^ DCs are individually redundant but are together required to imprint gut-homing receptors on T reg cells in the MLN, thereby maintaining normal numbers of T reg cells in the LP.

![**CD103^+^ DCs are required for LP T reg cells.** (A and B) Cell suspensions from the indicated tissues were stained ex vivo for intracellular FoxP3 and enumerated by flow cytometry (*n* = 10--12 mice per group). (C) Representative flow plots of MLNs gated on CD3ε^+^ CD8α^−^ CD4^+^ FoxP3^+^ cells and stained with isotype control (top left, wild-type mouse) or anti-CCR9 antibody (indicated genotypes). (D) Frequency of CCR9^+^ MLN T reg cells in mice of indicated genotype. All data are presented as mean ± SEM and symbols represent individual mice. Animals are pooled from three different experiments. Statistics were calculated by unpaired Student's *t* tests, using Welch's correction in B. \*\*, P ≤ 0.01; \*\*\*, P ≤ 0.001.](JEM_20130728_Fig6){#fig6}

CD103^+^CD11b^+^ DCs do not shape the microbiome
------------------------------------------------

Numerous studies have demonstrated that the presence of specific commensal microorganisms in the intestine direct host immune development ([@bib12]; [@bib33]). In contrast, the capacity of the host immune system to shape the intestinal microbiome has been less robustly examined. We have now characterized two genetic mouse models in which intestinal DC subsets have been ablated, leading to either reduced numbers of Th17 cells (huLangerin-DTA mice) or reduced numbers of both Th17 and T reg cells (DTAxBatF3^−/−^ mice) in the LP. To test whether these immune alterations affect the intestinal microbiome, we obtained fresh fecal pellets and scraped cecal contents from age- and sex-matched huLangerin-DTA and wild-type littermate controls. We also sampled DTAxBatF3^−/−^ mice and BatF3^−/−^ littermate controls. We then performed high-throughput sequencing on 16S bacterial rDNA amplified from these samples. A total of 1.11 × 10^8^ paired-end sequence reads (2 × 100 nt) were generated, with 2.17 × 10^5^ sequence reads per sample meeting our quality criteria. From these reads, 19,592 operational taxonomic units (OTUs) were identified among all samples, with a mean of 2,338 ± 261 OTUs present in individual samples. Sequence analyses identified a total of 28 phyla, which were dominated by Firmicutes (49 ± 7%), Bacteroidetes (21 ± 8%), and Proteobacteria (13 ± 5%; [Fig. 7, A and B](#fig7){ref-type="fig"}).

![**Loss of CD103^+^CD11b^+^ LP DCs does not alter commensal microbial communities.** (A and B) Phylogenetic classification of 16S rDNA sequence reads obtained from colonic fecal samples of wild-type/huLangerin-DTA littermates (A) or BatF3^−/−^/DTAxBatF3^−/−^ littermates (B). Bars represent bacterial phyla present in individual mice (7 mice per genotype). (C--F) Principal component plots comparing overall bacterial composition in colonic (C and E) or cecal (D and F) stool samples. Symbols in C--F represent individual mice. P-values represent unweighted UniFrac comparisons of huLangerin-DTA or DTAxBatF3^−/−^ animals to their respective wild-type or BatF3^−/−^ littermates at each anatomical site.](JEM_20130728_Fig7){#fig7}

Nonmetric multidimensional scaling (NMDS) on the Bray-Curtis distance matrix was used to visualize microbial community structure along axes of maximal variance ([@bib6]). Unweighted UniFrac analysis revealed that the loss of CD103^+^CD11b^+^ DCs and LP Th17 cells in huLangerin-DTA mice did not significantly affect the microbial composition in colonic ([Fig. 7 C](#fig7){ref-type="fig"}) or cecal ([Fig. 7 D](#fig7){ref-type="fig"}) contents (P = 0.962 and P = 0.662, respectively). There were also no significant differences in Shannon and Simpson diversity indices between groups (unpublished data). Of note, we did observe clustering of different litters, most evident in the cecum, demonstrating the importance of parental transmission in shaping steady-state gut microbial ecology. Similarly, the reduction of T reg cells and Th17 cells in the LP attendant with deletion of all CD103^+^ DCs in DTAxBatF3^−/−^ animals also did not significantly alter composition of the colonic ([Fig. 7 E](#fig7){ref-type="fig"}) or cecal ([Fig. 7 F](#fig7){ref-type="fig"}) microbiota (P = 0.683 and P = 0.959, respectively). Thus, the absence of CD103^+^CD11b^+^ LP DCs, as well as reduced numbers of Th17 and T reg cells in the LP, does not significantly affect the composition of the steady-state enteric microflora.

DISCUSSION
==========

Here, we report that huLangerin-DTA mice that were developed to target LCs in the skin also have a robust and selective ablation of CD103^+^CD11b^+^ LP DCs. Unlike mice with genetic ablation of factors required for DC subset development, transgenic expression of diphtheria toxin results in a highly specific ablation of individual DC subsets without alterations in the numbers of other DC subsets. The absence of CD103^+^CD11b^+^ DCs in the LP and mesenteric LN in huLangerin-DTA mice allowed us to examine the functional requirements of this subset in vivo.

LP Th17 cells contribute to autoimmune disease in humans and in animal models ([@bib47]; [@bib33]). Given this pathogenic potential, it is important to understand the mechanisms promoting LP Th17 differentiation. In agreement with other models that target CD103^+^CD11b^+^ DCs ([@bib48]; [@bib56]; [@bib57]), we observed that the frequency of Th17 cells in the LP was greatly reduced in the absence of CD103^+^CD11b^+^ DCs. Other LP-resident T cell subsets were unaffected. Specific commensal species and bacterial products are sufficient to generate Th17 cells in the LP ([@bib1]; [@bib37]). Thus, the reduction in Th17 cells could potentially result from a decrease in the overall number of DCs presenting commensal antigens. Notably, Th17 development was not affected in Batf3^−/−^ mice that lack CD103^+^CD11b^−^ DCs, and DTAxBatF3^−/−^ mice had a reduction of Th17 cells similar to that observed in huLangerin-DTA mice. Thus, CD103^+^CD11b^+^ DCs have a nonredundant role in LP Th17 development that is independent of CD103^+^CD11b^−^ DCs.

The cytokines required for Th17 differentiation in the LP are controversial, but include IL-1β, IL-6, and TGFβ ([@bib1]; [@bib36]; [@bib34]; [@bib61]). Consistent with a reduction of Th17 cells in huLangerin-DTA mice, CD103^+^CD11b^+^ DCs produce ∼5--10 fold more these cytokines than CD103^+^CD11b^−^ DCs (unpublished data; [@bib17]; [@bib24]). Remarkably, Th17 differentiation was intact in huLangerin-Cre I-Aβ^fl/fl^ mice. Thus, direct antigen presentation by CD103^+^CD11b^+^ DCs is not required for Th17 development, arguing that this DC subset is rather required to establish the appropriate cytokine milieu for Th17 differentiation. Though reported to occur during certain infections ([@bib55]), DCs driving T helper differentiation under steady-state conditions through noncognate interactions in vivo is a novel observation. The identity of the cell type that presents antigen remains unclear. Interestingly, Th17 cells can be generated by commensals even in transgenic mice that presumably lack T cell antigen receptors capable of recognizing antigen derived from these microbes, suggesting that cognate DC--T cell interactions may not be required ([@bib49]).

Earlier reports have suggested that CD103^+^CD11b^+^ DCs are required for flagellin-induced expression of IL-22 and to transport bacterial antigens from the LP to the MLN during infection with *S. typhimurium* ([@bib5]; [@bib45]). In contrast to these studies, huLangerin-DTA mice showed no defects in flagellin-induced IL-22 production or in protection from the IL-22/IL-23--dependent pathogen *C. rodentium*. huLangerin-DTA mice also mounted appropriate innate and adaptive immune responses to *S. typhimurium*. These differences may be due to different DC deletion strategies used in these studies and to potential functional overlap between known DC and/or macrophage subsets. Alternatively, these discrepancies may point to a functional importance for Flt3-dependent CD103^−^ DCs in the LP that have been recently identified ([@bib8]).

CD103^+^ DCs generate T reg cells in vitro through a RA-dependent mechanism ([@bib15]; [@bib63]; [@bib39]). The particular CD103^+^ DC subset responsible for T reg cell development in vivo has not been identified because both CD103^+^ LP DC subsets, as well as CX~3~CR1^+^ macrophages, have the capacity to metabolize RA and to induce T reg cells in vitro ([@bib28]; [@bib17]). In agreement with others, we show that, in vivo, neither CD103^+^ DC subset is individually required for T reg cell homeostasis ([@bib20]; [@bib48]). The reduction of T reg cells in DTAxBatF3^−/−^ mice reconciles the in vitro and in vivo data by demonstrating that, though mutually redundant, CD103^+^ DC subsets are jointly required to imprint CCR9^+^ T reg cells in the MLN and thereby maintain normal T reg cell numbers in the LP. Whether CD103^+^ DCs are required for antigen presentation or are an obligate source of RA cannot be distinguished. It is surprising that, despite a reduction in LP T reg cells, we did not observe enhanced steady-state or DSS-induced inflammatory pathology in DTAxBatF3^−/−^ mice. This may result from the concomitant reduction in Th17 cells or the microbial flora found in our animal facility.

The significance of intestinal commensal microorganisms in establishing and maintaining normal gut immune maturation is very well appreciated ([@bib33]). In contrast, the role played by the intestinal immune system in determining the constituents of the commensal microbial community has been less rigorously explored. Altered intestinal microbial communities that result from genetic defects have been reported for Nalp6^−/−^ and Tbet^−/−^ Rag2^−/−^ mice ([@bib21]; [@bib25]). Altered commensalism in these mice occurs in the setting of spontaneous inflammatory bowel disease. Because huLangerin-DTA and DTAxBatF3^−/−^ mice do not develop inflammation, they can be used to test whether DCs and LP-resident T cells regulate steady-state intestinal commensal communities. Remarkably, despite the absence of CD103^+^ LP DCs and defects in LP T reg cells and Th17 cells, we did not observe any alteration in the intestinal microbiome of these mice. This is not the result of a technical limitation, as we were able to detect differences resulting from vertical transmission of maternal flora ([@bib64]). Our data thus support a model in which the adaptive immune system, with the exception of IgA ([@bib23]), has a limited role in shaping the intestinal microbiome.

In this study, we report novel in vivo tools and provide strong evidence that distinct intestinal DC subsets make essential contributions to the maturation of the intestinal adaptive immune system. Future work with these tools will provide additional insight into the mechanisms through which specific LP DC subsets interact with both commensal and pathogenic microbes to shape immune responses, key considerations for the development of future therapeutics.

MATERIALS AND METHODS
=====================

### Mice.

All strains were backcrossed for at least eight generations onto the C57BL/6 genetic background. huLangerin-Cre *Rosa26*-Stop^fl^-YFP ([@bib41]), muLangerin-EGFP ([@bib46]), huLangerin-DTA ([@bib40]), and IL-23 p19^−/−^ ([@bib26]) mice have all been previously described. BatF3^−/−^ mice ([@bib32]) were a gift from K. Murphy (Washington University, St. Louis, MO). Experiments were performed with 6--12-wk-old age- and sex-matched, cohoused littermates. Mice were housed in specific pathogen--free microisolator cages and fed irradiated food and acidified water. The University of Minnesota Institutional Animal Care and Use Committee approved all animal protocols.

### Immunohistochemistry.

Tissues were washed in PBS and fixed in 10 volumes of 1% phosphate-buffered paraformaldehyde containing 75 mM [l]{.smallcaps}-lysine (Sigma-Aldrich) and 10 mM NaIO~4~ (Sigma-Aldrich). Tissues were then washed and dehydrated in 15% sucrose to preserve tissue architecture. Fixed, dehydrated samples were embedded in OCT compound (Tissue-Tek) before freezing, cutting, and mounting. Sections were then blocked and stained with fluorochrome-conjugated and biotinylated antibodies and DAPI. Fluorochrome-conjugated streptavidin secondary was used to detect biotinylated antibodies. Stained tissues were imaged using a DM5500B epifluorescent microscope (Leica).

### LP cell isolation.

Small intestines were dissected and cleaned in situ of mesenteric fat and connective tissue. Peyer's patches were removed with scissors and the entire small intestine was cut into 1 cm pieces for digestion. These pieces were first washed in HBSS before incubation at 37°C for 20 min in 3% RPMI containing 1 mM DTT, and 5 mM EDTA. The supernatant, containing the IEL fraction, was discarded. The remaining LP fraction was then washed twice in RPMI with 2 mM EDTA before digestion with 0.1 mg/ml Liberase TL (Roche) and 0.05 mg/ml DNase (Sigma-Aldrich) for 30 min at 37°C. LP suspensions were passed through a 70-µm filter, washed, and resuspended in 5 ml Histopaque-1077 (Sigma-Aldrich) to enrich for lymphocytes. Samples were overlaid with 2 ml RPMI before room-temperature centrifugation at 2,000 g for 30 min with no break. The interface was collected and cells were washed before staining and analysis by flow cytometry.

### Flow cytometry.

Single-cell suspensions from lymph nodes or small intestine LP were stained with fluorochrome-conjugated antibodies to CD3ε, CD4, CD8α, CD44, CCR9, CD11c, CD64, B220, I-A/I-E (MHCII), CD103, and CD11b purchased from BioLegend. Fixable viability dye and antibodies against FoxP3, IFN-γ, and IL-17A were purchased from eBioscience, anti-TCRγδ was obtained from BD, anti-huLangerin was purchased from Dendritics, and anti-GFP was obtained from Rockland. For evaluating cytokine expression, cells were stimulated for 3 h with PMA (50 ng/ml) and ionomycin (1.5 µM; Sigma-Aldrich) in complete DMEM media in the presence of brefeldin A for the final 2.5 h. Intracellular staining for FoxP3, GFP, or cytokines was performed with Cytofix/Cytoperm kit (BD) in accordance with the manufacturer's instructions. Detection of 2W1S-specific CD4 T cells was performed as previously described ([@bib53]) with an I-Aβ-2W1S tetramer, a gift from M. Jenkins. Stained samples were analyzed on an LSRFortessa flow cytometer (BD), and data were processed using FlowJo software (Tree Star). Cell numbers were calculated from flow cytometry frequencies using hemocytometer counts of Trypan blue--excluding cells.

### Flagellin injection and LP mRNA extraction.

1 µg ultrapure flagellin (InvivoGen) in sterile PBS was injected intravenously through the tail vein. 2 h later, a 1.5-cm segment of proximal small intestine 2 cm distal to the pylorus was dissected and opened longitudinally with scissors. Peyer's patches were removed from this segment before incubation at 37°C for 15 min in HBSS containing 25 mM Hepes, 1 mM DTT, and 10 mM EDTA to remove the epithelium. Segments were then pulse-vortexed eight times and washed in sterile PBS before stabilization in RNAlater (QIAGEN) for mRNA extraction and analysis. To deplete LP DCs, CD11c-DTR mice were injected i.p. with 1 µg diphtheria toxin 18 h before flagellin injection.

### DSS colitis.

Animals were treated with 2 or 5% wt/vol DSS (MP Biomedicals) in the drinking water and monitored daily for weight loss, as previously described ([@bib68]).

### Infections.

*C. rodentium* strain DBS100 was purchased from the American Type Culture Collection. Bacteria were subcloned and cultured for 12 h overnight in Luria-Bertani media, harvested by centrifugation, and suspended in sterile PBS. Bacterial concentration was estimated by measuring optical density at 600 nm (OD 600) and confirmed by plating serial dilutions. Mice were starved for 12 h before orogastric inoculation with 2 × 10^9^ bacteria in 200 µl PBS by gavage.

For *S. enterica* infection, attenuated AroA^−^ *S. enterica* serovar Typhimurium expressing the 2W1S epitope was a gift from M. Jenkins (University of Minnesota, Minneapolis, MN) and K. Smith (University of Washington, Seattle, WA). Either this strain or the naturally streptomycin resistant wild-type *S. enterica* serovar Typhimurium strain SL1344 were subcloned and cultured as above in the presence of 0.1 mg/ml streptomycin. Bacteria were harvested and animals infected as above with 5 × 10^7^--10^8^ *S. enterica*. To induce *S. enterica*-dependent enterocolitis, animals were treated as previously described ([@bib2]). In brief, mice were pretreated by gavage with 20 mg streptomycin sulfate in 100 µl sterile PBS. 24 hours later, mice were gavaged with 100 µl 5% NaHCO~3~, pH 9.0, before orogastric inoculation with 5 × 10^7^ *S. typhimurium* strain SL1344. Live bacterial loads were determined at indicated time points after infection by homogenizing tissues in 0.1% Triton X-100 buffer and plating serial dilutions on MacConkey agar.

### Fecal sample collection and bacterial DNA extraction.

Immediately after euthanization, fresh fecal pellets were obtained from the distal colon. Ceca were then opened with sterile scissors and cecal contents were scraped out with forceps. All samples were immediately frozen and stored in sterile microfuge tubes at −80°C. DNA was extracted from samples using the PowerSoil DNA extraction kit (MoBio) in accordance with the manufacturer's instructions. Approximately 0.3 g of each sample was used for extraction.

### 16S rDNA amplification and pyrosequencing.

DNA extracts were normalized to a concentration of 2.5 ng µl^−1^ by dilution in nuclease-free water and used as template for a PCR assay targeting the hypervariable V6 region of the 16S rDNA using the 967F/1046R primer set ([@bib62]). Each sample was amplified with a reverse primer containing a unique 6-bp nucleotide sequence on the 5′ terminus to allow samples to be pooled for sequencing and separated later ([@bib62]). Library construction and paired-end sequencing (2 × 100 nt) of amplicons was performed by the BioMedical Genomics Center at the University of Minnesota (Saint Paul, MN) using the Illumina HiSeq platform.

### 16S sequence analysis and statistics.

Raw sequence reads were pair-end aligned, separated by sample, and trimmed for quality as described previously using mothur software v. 1.27.0 ([@bib58]). Sequences of abundance \<2 over the entire dataset were excluded from analysis. Sequences were aligned to the RDP taxonomic database ([@bib13]), and analysis of OTUs was performed at a sequence cutoff of 0.03. The number of sequence reads associated with each group was subsampled to that of the smallest group (containing 217,483 sequences) for comparisons of β diversity and relative taxonomic abundance. Alpha diversity indices (Shannon, nonparametric Shannon, and Simpson indices) were calculated using mothur. The Bray-Curtis measure of dissimilarity was used to construct distance matrices among sites ([@bib6]). Unweighted UniFrac analyses ([@bib50]) and analysis of molecular variance (AMOVA; [@bib22]) were also calculated using mothur. Diversity indices and relative taxon abundance were compared via two-way analysis of variance (ANOVA) followed by Tukey's post-hoc test at α = 0.05 using SPSS Statistics software v. 19.0 (IBM).

### Quantitative real-time PCR.

RNA was extracted from RNAlater-stabilized tissues using an RNeasy mini kit (QIAGEN) according to the manufacturer's instructions. RNA was reverse-transcribed using a high-capacity cDNA RT kit and analyzed via qPCR with TaqMan Gene Expression Assays and an ABI 7900HT (Applied Biosystems) as previously described ([@bib30]). Data were normalized to Hprt expression, and relative expression values calculated using the comparative Ct method. Data are presented as 2^−ΔΔCt^.
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